CRISPR gene editing has made rapid progress heading from bench to bedside. Perhaps the fastest has been its progress toward clinical use to combat sickle cell disease. We’ll start with a new paper on one major effort here. CRISPR gene editing. This process often involves cutting DNA, which then can be used as an opening to …
Weekly reads: CRISPR sickle cell, Parkinson’s, pig-human chimera concerns Read More »
The post Weekly reads: CRISPR sickle cell, Parkinson’s, pig-human chimera concerns appeared first on The Niche.